New this week: articles across all of medicine

Showing the most recent five

Must Read F1000 Factor 6.0 Confirmation Hypothesis	Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users. Curtis JR, Westfall AO, ..., Saag KG, Delzell E J Bone Miner Res 2008 Sep 23 (9):1435-41 [abstract on PubMed] [related articles] [full text] [order article]
	Selected by | Jon Tobias with Emma Clark Evaluated 05 Sep 08

Exceptional F1000 Factor 9.0 New Finding	Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Kerem E, Hirawat S, ..., Kerem B, Wilschanski M Lancet 2008 Aug 30 372 (9640):719-27 [abstract on PubMed] [related articles] [full text] [order article]
	Selected by | Lea Bentur Evaluated 05 Sep 08

Recommended F1000 Factor 3.0 Hypothesis	Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. Gong Y, Hart E, Shchurin A, Hoover-Plow J J Clin Invest 2008 Aug 1 118:- [abstract on PubMed] [related articles] [FREE full text] [order article]
	Selected by | Rene Toes with Leendert A Trouw Evaluated 05 Sep 08

Recommended F1000 Factor 3.0 Tech Advance	Minority HIV-1 Variants in Antiretroviral Naive Persons with Reverse Transcriptase Codon 215 Revertant Mutations. Mitsuya Y, Varghese V, ..., Fessel WJ, Shafer RW J Virol 2008 Aug 20 :- [abstract on PubMed] [related articles] [full text] [order article]
	Selected by | Amalio Telenti Evaluated 05 Sep 08

Must Read F1000 Factor 6.0 New Finding Tech Advance	Transapical mitral valved stent implantation. Lozonschi L, Quaden R, ..., Cremer J, Lutter G Ann Thorac Surg 2008 Sep 86 (3):745-8 [abstract on PubMed] [related articles] [full text] [order article]
	Selected by | John Augoustides Evaluated 05 Sep 08

Read more